PR The PESO Model and Modern Way to Integrate Communications Efforts February 1, 2022 6 mins read 5176 Views We are all aware of struggles within the marketing mix specific to roles and functions. It’s an issue that has been around for as long as I have been .. Read More
CMO Innovent Updates Phase 1b Data of IBI939 (Anti-TIGIT Monoclonal Antibody) Combined with Sintilimab in Previously Untreated PD-L1-selected NSCLC at the 2023 ASCO Annual Meeting June 4 0 mins read 25 Views
 Header option 2.png)